LONDON, March 16 (Reuters) - Pfizer Inc, the world’s largest drugmaker, is planning a four-part benchmark bond denominated in U.S. dollars to help fund its purchase of Wyeth, one of the banks managing the sale said on Monday.
LONDON, March 16 (Reuters) - Pfizer Inc, the world’s largest drugmaker, is planning a four-part benchmark bond denominated in U.S. dollars to help fund its purchase of Wyeth, one of the banks managing the sale said on Monday.
